Stay updated on Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, reflecting a minor site update. The page content remains unchanged.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision label updated to v3.4.1 (replacing v3.4.0) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedGlossary display is now shown; a new 'Last Update Submitted that Met QC Criteria' label and a 'No FEAR Act Data' notice, along with revision information 'v3.4.0', have been added. The previous label 'Last Update Submitted that met QC Criteria' (different casing), 'No FEAR Act data', and the older revision 'v3.3.4' have been removed.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page shows a new revision tag (v3.3.4) replacing the previous v3.3.3; there are no apparent changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations section updated to include Hubei; Hubei Locations removed; Revision: v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page.